News | Janssen South Africa

A report published on 7 October shows that European research and development investments in health have stagnated since ...

Jane Griffiths, Company Group Chairman for Janssen EMEA and Chairwoman of the EFPIA executive committee, talks openly to...

On 6 January 2015 the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine was announced. It ...

Dutch documentary maker Erwin Kokkelkoren, shares his experience at the AIDS conference 2014 in Melbourne via a series o...

February 28 marks the 7th annual Rare Disease Day, an important international occasion to raise awareness of rare diseas...

On 25 September Jane Griffiths, Company Group Chairman, Janssen Europe, Middle East and Africa, hosted a multi-stakehold...

Although Tuberculosis (TB) is a curable and preventable disease, 1.3 million people died of the infection in 2012. In th...

Janssen Research and Development, LLC, has entered into an agreement with Yale School of Medicine’s Open Data Acce...

The European Patent Office named Drs. Koen Andries and Jérôme Guillemont and their research team the 2014 w...

“Uniting to Combat Neglected Tropical Diseases: A Conversation on Progress” is another initiative supported ...